Owens & Minor PE Ratio 2006-2020 | OMI

Current and historical p/e ratio for Owens & Minor (OMI) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Owens & Minor PE ratio as of July 03, 2020 is 12.27.
Owens & Minor PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-07-02 7.36 0.00
2020-03-31 9.15 $-1.00 0.00
2019-12-31 5.17 $-1.04 0.00
2019-09-30 5.81 $-4.76 0.00
2019-06-30 3.20 $-4.79 0.00
2019-03-31 4.10 $-7.68 0.00
2018-12-31 6.33 $-7.32 0.00
2018-09-30 16.33 $-2.57 0.00
2018-06-30 16.26 $-2.38 0.00
2018-03-31 14.89 $1.03 14.46
2017-12-31 17.80 $1.21 14.71
2017-09-30 27.16 $1.28 21.22
2017-06-30 29.68 $1.58 18.78
2017-03-31 31.64 $1.69 18.72
2016-12-31 32.04 $1.77 18.10
2016-09-30 31.31 $1.83 17.11
2016-06-30 33.45 $1.80 18.58
2016-03-31 35.92 $1.74 20.64
2015-12-31 31.77 $1.65 19.26
2015-09-30 28.01 $1.36 20.59
2015-06-30 29.59 $1.02 29.01
2015-03-31 29.24 $0.95 30.78
2014-12-31 30.11 $1.06 28.40
2014-09-30 27.87 $1.28 21.77
2014-06-30 28.72 $1.61 17.84
2014-03-31 29.39 $1.75 16.80
2013-12-31 30.46 $1.75 17.40
2013-09-30 28.63 $1.70 16.84
2013-06-30 27.80 $1.65 16.85
2013-03-31 26.57 $1.67 15.91
2012-12-31 23.09 $1.72 13.42
2012-09-30 24.01 $1.71 14.04
2012-06-30 24.43 $1.85 13.20
2012-03-31 24.07 $1.83 13.15
2011-12-31 21.83 $1.82 12.00
2011-09-30 22.22 $1.78 12.48
2011-06-30 26.72 $1.75 15.27
2011-03-31 25.01 $1.75 14.29
2010-12-31 22.51 $1.74 12.94
2010-09-30 21.63 $1.91 11.31
2010-06-30 21.43 $1.97 10.90
2010-03-31 23.08 $1.89 12.23
2009-12-31 21.23 $1.67 12.69
2009-09-30 22.26 $1.49 14.97
2009-06-30 21.44 $1.34 16.00
2009-03-31 16.11 $1.34 12.02
2008-12-31 18.18 $1.51 12.06
2008-09-30 23.29 $1.55 15.06
2008-06-30 21.84 $1.49 14.69
2008-03-31 18.73 $1.41 13.31
2007-12-31 20.10 $1.19 16.84
2007-09-30 17.97 $0.95 18.98
2007-06-30 16.41 $0.84 19.54
2007-03-31 17.17 $0.71 24.07
2006-12-31 14.54 $0.81 18.03
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.464B $9.211B
Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $163.141B 28.29
Medtronic (MDT) Ireland $124.955B 20.30
Stryker (SYK) United States $68.946B 22.38
Boston Scientific (BSX) United States $49.509B 23.28
Baxter (BAX) United States $44.233B 0.00
Lonza Group Ag (LZAGY) Switzerland $39.871B 0.00
Terumo (TRUMY) Japan $29.963B 38.30
EssilorLuxottica Societe Anonyme (ESLOY) France $28.693B 0.00
ResMed (RMD) United States $27.846B 43.94
Zimmer Biomet Holdings (ZBH) United States $24.894B 15.66
Smith & Nephew SNATS (SNN) United Kingdom $17.257B 0.00
Sunny Optical Technology (SNPTF) China $16.924B 0.00
Bio-Rad Laboratories (BIO) United States $13.589B 61.86
Insulet (PODD) United States $12.687B 1256.94
DiaSorin S.p.A (DSRLF) Italy $10.994B 0.00
Quidel (QDEL) United States $9.535B 74.93
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
Perrigo (PRGO) Ireland $7.523B 13.46
Hill-Rom Holdings (HRC) United States $7.426B 20.93
GN STORE NORD (GNNDY) Denmark $6.972B 35.54
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.771B 0.00
Haemonetics (HAE) United States $4.656B 27.96
Neogen (NEOG) United States $4.108B 69.58
GW Pharmaceuticals (GWPH) United Kingdom $3.892B 0.00
ICU Medical (ICUI) United States $3.890B 28.38
Agios Pharmaceuticals (AGIO) United States $3.836B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.805B 0.00
Envista Holdings (NVST) United States $3.407B 0.00
NuVasive (NUVA) United States $2.925B 23.49
National Vision Holdings (EYE) United States $2.458B 42.53
TG Therapeutics (TGTX) United States $2.213B 0.00
AtriCure (ATRC) United States $1.855B 0.00
MacroGenics (MGNX) United States $1.450B 0.00
Aurora Cannabis (ACB) Canada $1.390B 0.00
NanoString Technologies (NSTG) United States $1.322B 0.00
Aphria (APHA) Canada $1.231B 0.00
Cardiovascular Systems (CSII) United States $1.137B 0.00
Cerus (CERS) United States $1.109B 0.00
Phibro Animal Health (PAHC) United States $1.055B 21.02
Meridian Bioscience (VIVO) United States $1.019B 38.37
PetIQ (PETQ) United States $1.017B 29.37
DFB Healthcare Acquisitions (AHCO) United States $0.924B 0.00
InMode (INMD) Israel $0.897B 18.97
Vapotherm (VAPO) United States $0.881B 0.00
Zynex (ZYXI) United States $0.834B 83.73
Omeros (OMER) United States $0.826B 0.00
Quanterix (QTRX) United States $0.789B 0.00
OraSure Technologies (OSUR) United States $0.746B 150.25
Eagle Pharmaceuticals (EGRX) United States $0.663B 47.51
Surmodics (SRDX) United States $0.585B 70.49
VAREX IMAGING (VREX) United States $0.584B 14.51
Lantheus Holdings (LNTH) United States $0.579B 11.65
LeMaitre Vascular (LMAT) United States $0.532B 30.29
BioLife Solutions (BLFS) United States $0.467B 163.46
Viemed Healthcare (VMD) United States $0.367B 32.55
Cytosorbents (CTSO) United States $0.361B 0.00
HEXO (HEXO) $0.322B 0.00
Utah Medical Products (UTMD) United States $0.315B 22.85
Neptune Wellness Solutions (NEPT) Canada $0.304B 0.00
Organigram Holdings (OGI) Canada $0.285B 0.00
Female Health (VERU) United States $0.229B 0.00
Chimerix (CMRX) United States $0.196B 0.00
Bovie Medical (APYX) United States $0.185B 0.00
Evolus (EOLS) United States $0.185B 0.00
Surface Oncology (SURF) United States $0.178B 0.00
Exagen (XGN) United States $0.161B 0.00
Fonar (FONR) United States $0.135B 11.94
Rockwell Medical (RMTI) United States $0.133B 0.00
United Health Products (UEEC) United States $0.131B 0.00
Liberty Health Sciences (LHSIF) Canada $0.120B 0.00
Wound Management Technologies (SMTI) United States $0.112B 0.00
MTech Acquisition (KERN) United States $0.109B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.084B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.082B 0.00
Nephros (NEPH) United States $0.073B 0.00
United-Guardian (UG) United States $0.071B 16.51
Capricor Therapeutics (CAPR) United States $0.065B 0.00
Brainsway (BWAY) Israel $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.055B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.012B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00